[HTML][HTML] The role of collagen in thrombosis and hemostasis

RW Farndale, JJ Sixma, MJ Barnes… - Journal of Thrombosis and …, 2004 - Elsevier
Collagens represent up to 40% of the total protein of the vessel wall, forming an insoluble
scaffold which is essential for tissue integrity and which provides a surface for the …

Platelet glycoprotein VI: its structure and function

M Moroi, SM Jung - Thrombosis research, 2004 - Elsevier
Glycoprotein (GP) VI is a platelet membrane protein with a molecular weight of 62 kDa that
was identified as a physiological collagen receptor from studies of patients deficient in this …

Anti-GPVI–associated ITP: An acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface

B Boylan, H Chen, V Rathore, C Paddock, M Salacz… - Blood, 2004 - ashpublications.org
Platelet glycoprotein (GP) VI is a 62-kDa membrane glycoprotein that exists on both human
and murine platelets in a noncovalent complex with the Fc receptor (FcR) γ chain. The …

Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome

P Nurden, M Jandrot-Perrus, R Combrié, J Winckler… - Blood, 2004 - ashpublications.org
We report a novel case of gray platelet syndrome (GPS) where a severe deficiency of the
platelet collagen receptor, glycoprotein (GP) VI, accompanies classical symptoms of a low …

Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men

E Ollikainen, J Mikkelsson, M Perola, A Penttilä… - Atherosclerosis, 2004 - Elsevier
Glycoprotein VI is a platelet collagen receptor binding to subendothelial collagen after a
rupture of an atherosclerotic plaque. The GPVI gene is polymorphic with several SNPs and …

Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H (P) ETE synthesis

MJ Coffey, GE Jarvis, JM Gibbins, B Coles… - Circulation …, 2004 - Am Heart Assoc
Lipoxygenases (LOX) contribute to vascular disease and inflammation through generation of
bioactive lipids, including 12-hydro (pero) xyeicosatetraenoic acid (12-H (P) ETE). The …

Platelet-collagen responses: molecular basis and therapeutic promise

ML Kahn - Seminars in thrombosis and hemostasis, 2004 - thieme-connect.com
Exposure of circulating blood to collagen after vessel injury has been recognized as a
primary event in arterial thrombosis for many years but an understanding of the molecular …

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

TJ Kunicki, AB Federici, DR Salomon, JA Koziol… - Blood, 2004 - ashpublications.org
Abstract von Willebrand disease (VWD) type 1 is difficult to diagnose because of bleeding
variability and low heritability of von Willebrand factor (VWF) levels. We compared a …

Clinical and functional consequences of platelet membrane glycoprotein polymorphisms

DL Yee, PF Bray - Seminars in thrombosis and hemostasis, 2004 - thieme-connect.com
The last several years have seen an abundance of studies of genetic risk factors for vascular
disease, and platelet glycoprotein (GP) polymorphisms have been a primary focus of this …

[PDF][PDF] Platelet antigens and their function

H Deckmyn, H Ulrichts, G Van de Walle… - Vox …, 2004 - biblio.ugent.be
Based on the detailed study of the antigens that are recognized by alloantibodies, for
example, polymorphisms on a number of platelet receptors have been identified and …